CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Pierre Fabre SA is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Pierre Fabre SA
Zone Industrielle de la Chartreuse
Phone: +33 563623850p:+33 563623850 CASTRES, 81100  France
Business Summary
Pierre Fabre SA is a France-based company engaged in the pharmaceutical industry. The Company is organized around three activities: pharmacy, dermo-cosmetics and family medication. The pharmacy activity regroups the activities of Pierre Fabre Medicaments, which operates research and development and pharmaceutical production activities on specifically targeted therapeutic lines, including cancerology, urology, cardiology, psychoatry, phlebology, pneumology, infectiology, gynaecology and rhumatology. The dermo-cosmetics activities are operated by Pierre Fabre Dermo-Cosmetique, which provides dermatology products under the Avene, Ducray, A-Derma and Pierre Fabre Dermatology brands, and dermo-pharmacy products under the Galenic, Kloran and Rene Furterer brand names. The family medication activity regroups the operations of Pierre Fabre Sante, which together with Pierre Fabre ORAL CARE, Elusept and Naturactive, design, manufacture and distribute prevention and public health drugs.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/201312/31/2013Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research
2844 Perfumes, cosmetics, and other toilet preparations
2833 Medicinal chemicals and botanical products
2099 Food preparations, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Supervisory Board RochDeliveux 12/31/2021 12/31/2021
Group Chief Executive Officer EricDucournau 12/31/2021 1/1/2014
Non-Executive Vice Chairman of the Supervisory Board, Chairman of Pierre Fabre Participations Pierre-YvesRevol 12/31/2021 1/1/2014
Chief Executive Officer of Medical Care Business Unit Jean-lucLowinski
Senior Vice President - Human Resources AgnesPark

Subsidiaries
Business Name Address City State/Province Country
Pierre Fabre Medicament SA 45 Place Abel Gance Hauts De Seine France

Business Names
Business Name
Pierre Fabre Company
Pierre Fabre Medicament

General Information
Outstanding Shares: 23,684,090 (As of 12/31/2013)


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, August 30, 2023